Nan Fung Group Holdings Ltd - AKERO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Nan Fung Group Holdings Ltd ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$223,817
+8.3%
4,4250.0%0.18%
+37.1%
Q2 2023$206,603
+164.9%
4,425
+27.5%
0.13%
+428.0%
Q3 2021$78,000
-9.3%
3,4700.0%0.02%
-7.4%
Q2 2021$86,0003,4700.03%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$179,512,00024.20%
venBio Partners LLC 2,444,311$75,260,00011.44%
Versant Venture Management, LLC 777,727$23,946,0004.38%
Redmile Group, LLC 2,336,357$71,936,0001.32%
Vivo Capital, LLC 571,833$17,607,0001.02%
Cormorant Asset Management, LP 859,550$26,466,0001.02%
Boxer Capital, LLC 831,495$25,602,0000.88%
Integral Health Asset Management, LLC 85,000$2,617,0000.80%
EAM Global Investors LLC 49,718$1,531,0000.56%
Crawford Lake Capital Management, LLC 43,826$1,349,0000.56%
View complete list of AKERO THERAPEUTICS INC shareholders